Back
VYNE Therapeutics Vs. Theriva Biologics Industry Stock Comparison
Sell
27
VYNE
VYNE Therapeutics
Last Price:
1.89
Seasonality Move:
-14.98%
Buy
74
TOVX
Theriva Biologics
Last Price:
3.98
Seasonality Move:
-14.85%
Sell
27
VYNE Therapeutics (VYNE)
is a Sell
Is VYNE Therapeutics a Buy, Sell or Hold?
- The current VYNE Therapeutics [VYNE] share price is $1.86. The Score for VYNE is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- VYNE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
74
Theriva Biologics (TOVX)
is a Buy
Is Theriva Biologics a Buy, Sell or Hold?
- The current Theriva Biologics [TOVX] share price is $3.95. The Score for TOVX is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- TOVX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VYNE Stock Price Chart
What is VYNE Therapeutics's stock price today?
-
The VYNE Therapeutics share price today is $1.86
The current trend is relatively stagnant and VYNE is experiencing selling pressure, which indicates risk of future bearish movement.
TOVX Stock Price Chart
What is Theriva Biologics's stock price today?
-
The Theriva Biologics share price today is $3.95
The current trend is moderately bullish and TOVX is experiencing slight selling pressure.
VYNE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 50.45 | Buy |
| Chaikin Money Flow: | -40914 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.79 - 1.89) | Buy |
| Bollinger Bands (100): | (1.77 - 2.49) | Sell |
TOVX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.79 | Buy |
| Relative Strength Index (14 RSI): | 47.04 | Sell |
| Chaikin Money Flow: | -11576 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.89 - 4.57) | Buy |
| Bollinger Bands (100): | (-0.5 - 2.3) | Buy |
VYNE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.84 | Buy |
| 20-day SMA: | 1.85 | Buy |
| 50-day SMA: | 1.9 | Sell |
| 200-day SMA: | 2.25 | Sell |
| 8-day EMA: | 1.85 | Buy |
| 20-day EMA: | 1.85 | Buy |
| 50-day EMA: | 1.91 | Sell |
| 200-day EMA: | 2.47 | Sell |
TOVX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.94 | Buy |
| 20-day SMA: | 3.37 | Buy |
| 50-day SMA: | 1.49 | Buy |
| 200-day SMA: | 0.69 | Buy |
| 8-day EMA: | 3.89 | Buy |
| 20-day EMA: | 3.26 | Buy |
| 50-day EMA: | 2.06 | Buy |
| 200-day EMA: | 0.94 | Buy |
VYNE Therapeutics Earnings Growth & VYNE Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.25 per share, and a decrease next year of $1.05 per share.
Theriva Biologics Earnings Growth & TOVX Earnings Dates
- Analysts estimate an earnings increase this quarter of $3.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.00 per share, and an increase next year of $22.60 per share.
VYNE Therapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Theriva Biologics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||